Institutional investors purchased a net $251.2 thousand shares of THOR during the quarter ended March 2015 and now own 96.36% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PALO ALTO INVESTORS LLC Bought 2.3 Million shares of Thoratec Corp
NEUBERGER BERMAN LLC Bought 1.1 Million shares of Thoratec Corp
EAGLE ASSET MANAGEMENT, INC. Bought 621.6 Thousand shares of Thoratec Corp